Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

Back to all news

Congressional Briefing on Counterfeit Drugs Feb. 28, 2023

Posted 2/15/2023

This event is open to the public. Breakfast will be served from 8-830am.

Counterfeit medicines are a threat to patients, and while the U.S. drug supply is the safest in the world, it is under constant threat from criminals attempting to defraud patients and healthcare professionals.

This live briefing is the final event in a series of briefings being done for the 118th Congress. View all the briefing videos on our website:

Introduction: Tom Kubic, PSM Board Chair, Federal Bureau of Investigation (ret)

Keynote: Sen. Rick Scott (R-FL) (confirmed)

Tutorial: The Drug Supply Chain Security Act, online pharmacies, and recent counterfeits in the supply chain. (Presenter: Shabbir Imber Safdar, PSM)

Panel Talk: Foreign drug importation: U.S. and foreign stakeholders talk about the problems implementing this policy.

  • Moderator: Shabbir Imber Safdar, PSM Executive Director
  • Panelist: Joelle Walker, VP Public Affairs, Canadian Pharmacist Association
  • Panelist: Oksana Pyzik, Pharmacist & Global Health Advisor, University College London School of Pharmacy (invited)

Panel Talk: Social media, fake medicines, and drug sales: Parent advocates, law enforcement, and legislative staff talk about ways to hold illegal drug sellers on social media responsible.

  • Moderator: Shabbir Imber Safdar, PSM Executive Director
  • Panelist: Amy Neville @ Alexander Neville Foundation
  • Panelist: Natasha Butler, mother of Jerome Butler
  • Panelist: Canyon County Sheriff Kieran Donahue (invited)
  • Panelist: Additional Senate staff (invited)

Free Registration:

Back to all news

Sponsor Spotlight

COMPASS Pathways

COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more

All Sponsors